Results 1-6 of 6 (Search time: 0.004 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2018 | FAM198B Is Associated with Prolonged Survival and Inhibits Metastasis in Lung Adenocarcinoma via Blockage of ERK-Mediated MMP-1 Expression. | Hsu, CY; Chang, GC; Chen, YJ; Hsu, YC; Hsiao, YJ; Su, KY; Chen, HY ; Lin, CY; Chen, JS; Chen, YJ; Hong, QS; Ku, WH; Wu, CY; Ho, BC; Chiang, CC; Yang, PC; Yu, SL | Clinical cancer research : an official journal of the American Association for Cancer Research 24(4), 916-926 | |||
2 | 2016 | JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer. | Chang, WH; Ho, BC; Hsiao, YJ; Chen, JS; Yeh, CH; Chen, HY ; Chang, GC; Su, KY; Yu, SL | PloS one 11(3), e0150355 | |||
3 | 2016 | Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice | Su, KY; Kao, JT; Ho, BC; Chen, HY ; Chang, GC; Ho, CC; Yu, SL | Scientific reports 6, 30944 | |||
4 | 2016 | SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma | Hsiao, YJ; Su, KY; Hsu, YC; Chang, GC; Chen, JS; Chen, HY ; Hong, QS; Hsu, SC; Kang, PH; Hsu, CY; Ho, BC; Yang, TH; Wang, CY; Jou, YS; Yang, PC; Yu, SL | Oncotarget 7, 44417-44429 | |||
5 | 2016 | Molecular gene signature and prognosis of non-small cell lung cancer | Huang, P; Cheng, CL; Chang, YH; Liu, CH; Hsu, YC; Chen, JS; Chang, GC; Ho, BC; Su, KY; Chen, HY ; Yu, SL | Oncotarget 7(32), 51898-51907 | |||
6 | 2015 | R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability | Chen, HY ; Yu, SL; Ho, BC; Su, KY; Hsu, YC; Chang, CS; Li, YC; Yang, SY; Hsu, PY; Ho, H; Chang, YH; Chen, CY; Yang, HI ; Hsu, CP; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Hsia, JY; Chuang, CY; Yuan, S; Lee, MH; Liu, CH; Wu, GI; Hsiung, CA; Chen, YM; Wang, CL; Huang, MS; Yu, CJ; Chen, KY; Tsai, YH; Su, WC; Chen, HW; Chen, JJ; Chen, CJ ; Chang, GC; Yang, PC; Li, KC | JOURNAL OF CLINICAL ONCOLOGY 33(20), 2303-2310 |